• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重以及报告的与测量的体重减轻作为地塞米松抑制试验的混杂因素。

Body weight and reported versus measured weight loss as confounders of the dexamethasone suppression test.

作者信息

Pfohl B, Coryell W, Stangl D, Zimmerman M

出版信息

Biol Psychiatry. 1986 Aug;21(10):931-8. doi: 10.1016/0006-3223(86)90267-2.

DOI:10.1016/0006-3223(86)90267-2
PMID:3741910
Abstract

We examined the association between post-dexamethasone suppression test (DST) serum cortisol and body weight, self-report of weight loss during the episode, and measured weight loss during the first week of admission in a series of 245 depressed inpatients. Data on measured weight loss between two successive admissions was available in a group of 57 depressed inpatients. Reported weight loss during the episode and measured weight loss during the first week of admission were not related to DST nonsuppression. In contrast, DST nonsuppression was significantly more frequent in patients with measured weight loss between two successive admissions. This association was particularly strong in patients with below-average body weight and was practically nonexistent in patients with above-average body weight. Multivariate analysis indicates that a significant association between DST results and weight loss may be missed if self-report is substituted for direct measurement of weight loss and if potential confounders, such as total body weight, age, and sex, are ignored.

摘要

我们在245名抑郁住院患者中,研究了地塞米松抑制试验(DST)后血清皮质醇与体重、发作期间体重减轻的自我报告以及入院第一周测量的体重减轻之间的关联。在一组57名抑郁住院患者中,可获得两次连续入院期间测量的体重减轻数据。发作期间报告的体重减轻和入院第一周测量的体重减轻与DST未被抑制无关。相比之下,在两次连续入院期间测量体重减轻的患者中,DST未被抑制的情况明显更频繁。这种关联在体重低于平均水平的患者中尤为强烈,而在体重高于平均水平的患者中几乎不存在。多变量分析表明,如果用自我报告代替体重减轻的直接测量,并且忽略诸如总体重、年龄和性别等潜在混杂因素,可能会遗漏DST结果与体重减轻之间的显著关联。

相似文献

1
Body weight and reported versus measured weight loss as confounders of the dexamethasone suppression test.体重以及报告的与测量的体重减轻作为地塞米松抑制试验的混杂因素。
Biol Psychiatry. 1986 Aug;21(10):931-8. doi: 10.1016/0006-3223(86)90267-2.
2
The dexamethasone suppression test in patients with mood disorders.情绪障碍患者的地塞米松抑制试验
J Clin Psychiatry. 1996 Oct;57(10):470-84. doi: 10.4088/jcp.v57n1006.
3
Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.抑郁症患者及对照组的治疗前地塞米松抑制试验与下丘脑-垂体-肾上腺皮质功能:一项多中心研究
Arch Gen Psychiatry. 1984 Mar;41(3):257-67. doi: 10.1001/archpsyc.1984.01790140047006.
4
Association between post-dexamethasone cortisol level and blood pressure in depressed inpatients.抑郁症住院患者地塞米松后皮质醇水平与血压之间的关联
J Nerv Ment Dis. 1991 Jan;179(1):44-7. doi: 10.1097/00005053-199101000-00009.
5
Dexamethasone suppression test response in major depression: stability across hospitalizations.重度抑郁症中地塞米松抑制试验反应:不同次住院期间的稳定性
Psychiatry Res. 1983 Mar;8(3):179-89. doi: 10.1016/0165-1781(83)90061-6.
6
Comparison of early and delayed inpatient dexamethasone suppression tests.
Psychiatry Res. 1989 Feb;27(2):161-71. doi: 10.1016/0165-1781(89)90131-5.
7
Measured weight loss and the dexamethasone suppression test.测量的体重减轻与地塞米松抑制试验。
Can J Psychiatry. 1989 Oct;34(7):707-9. doi: 10.1177/070674378903400715.
8
Serial dexamethasone suppression tests in psychiatric illness: Part III. The influence of intervening variables.精神疾病中的系列地塞米松抑制试验:第三部分。干预变量的影响。
Psychiatry Res. 1986 May;18(1):45-64. doi: 10.1016/0165-1781(86)90059-4.
9
Diagnostic heterogeneity and the DST in consecutive psychiatric admissions.连续精神科住院患者的诊断异质性与药物敏感试验
Psychiatry Res. 1985 Mar;14(3):215-23. doi: 10.1016/0165-1781(85)90016-2.
10
Results of the dexamethasone suppression test in psychiatric patients with and without weight loss.
Am J Psychiatry. 1985 Feb;142(2):246-8. doi: 10.1176/ajp.142.2.246.

引用本文的文献

1
Dexamethasone does not ameliorate gliosis in a mouse model of neurodegenerative disease.地塞米松不能改善神经退行性疾病小鼠模型中的胶质细胞增生。
Biochem Biophys Rep. 2020 Sep 24;24:100817. doi: 10.1016/j.bbrep.2020.100817. eCollection 2020 Dec.